SCHEMBL16970705

SCHEMBL16970705

Cc1ccc(N(CCOS(C)(=O)=O)CCOS(C)(=O)=O)cc1C[C@H](CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.33
▸ XBP1 P17861 3/20 0.33
▸ HTT P42858 3/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ PKM P14618 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ AAK1 Q2M2I8 2/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ JAK2 O60674 2/20 0.33
▸ S1PR4 O95977 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ CYP2D6 P10635 1/20 0.32
▸ SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28520953 1.00 LMNA (0.33) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL16970714 0.96 AAK1 (0.33) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL28511510 0.96 AAK1 (0.33) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL16970794 0.96 LMNA (0.32) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL18427935 0.93 ATM (0.35) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL16974967 0.93 ATM (0.35) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL23877849 0.89 IDO1 (0.35) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL18428023 0.89 AAK1 (0.33) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL16974955 0.89 IDO1 (0.35) LMNAXBP1HTTNPSR1HSP90AA1
SCHEMBL23877862 0.89 AAK1 (0.33) LMNAXBP1HTTNPSR1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394237-B2 β-substituted β-amino acids and analogs as chemotherapeutic agents QUADRIGA BIOSCIENCES, INC. (US) 2016-07-19 — — US disclosed
US-20150218086-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS QUADRIGA BIOSCIENCES, INC. 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218086-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS SLC7A1, SLC3A2, SLC1A5 LMNA 3813/4885XBP1 2923/4885HTT 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback